CNS Pharmaceuticals, Inc.
NASDAQ:CNSP
Overview | Financials
| Company Name | CNS Pharmaceuticals, Inc. |
| Symbol | CNSP |
| Currency | USD |
| Price | 6.39 |
| Market Cap | 3,671,534 |
| Dividend Yield | 0% |
| 52-week-range | 4.93 - 222 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Mr. John Michael Climaco Esq., J.D. |
| Website | https://www.cnspharma.com |
An error occurred while fetching data.
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD
